Under pathophysiologic conditions such as insulin resistance, obesity, and diabetes, PTP1B is often over-expressed in the liver, adipose tissue, muscle, and the nucleus of hypothalamus, suggesting that PTP1B may increase in response to certain inflammatory factors. Here, PTPN1 is linked to Insulin resistance.